Videos

An approval may be pending for the unique delivery system. An expert explains its benefit for nAMD patients and physicians alike.

Dr. Erickson discussed screening for children prone to sudden cardiac arrest and sudden cardiac death based on an updated AAP policy statement.

Dr. Michalsky discusses the utility of bariatric surgical options in patients with a high body mass index.

Dr. Carbone will present during AAP 2021 about managing autism in pediatric practices.

Dr. Fasipe shares her in-person experience viewing Phillip Okwo's Life Interrupted production about living with sickle cell disease.

Montefiore experts discuss the emphasis on education at their MFM-Cardiology care program.

An obstetrician-gynecologist and a cardiologist discuss the inception of their joint cardiovascular care program for expecting mothers.

Dr. Castro considers it to be a fruitful and exciting time in the study of asthma-modifying therapy, with some biologic therapies achieving control in patients with severe asthma.

Dr. Castro talks of the available biologic therapies that can be used to treat asthma and other respiratory disorders.

Dr. Ezhkova and fellow investigators found that low UV exposure prompted an increase in pigmentation production through melanocytes in the body.

An expert considers the buildup of cardiovascular and cardiometabolic innovation, and the role of regulatory delays in it.

How inclisiran, bempedoic acid, and other investigative therapies may contribute to cardiometabolic disease management.

A discussion on the winning qualities of the CARDIA study, and why it's also hard to replicate.

The cardiologist discusses the lagging nature of US health care authorization and recommendation for already proven agents in cardiovascular risk reduction.

The Tulane Chief of Endocrinology recalls Dr. Frederick Banting's historic discovery in 1921, and how it still impacts diabetes care today.

Women with gestational diabetes face a twice greater risk of developing cardiovascular disease. Investigators are still seeking understanding of the association.

A look at how European experts have shaped risk assessment through demographic-centric algorithms.

Dr. Grunberger believes that the improved time in range brought on by continual glucose monitoring could lead to a reduction in hypoglycemia and risk of cardiovascular events, as well as promising monetary benefits for patients and payers.

While some treatments did not result in reduced instances of strokes in patients, others such as GLP-1 agonists provided Dr. Inzucchi with new opportunities for cardiovascular disease prevention.

An expert weighs in on improving guidelines to reflect optimal real-world care for patients at high risk of cardiovascular events.

While drivers of gestational diabetes are not fully evidenced, data shows how it's linked to great likelihood of type 2 diabetes and cardiovascular events.

Dr. Chovatiya speaks on the advancements made in vitiligo research, how the disease can disproportionately impact patients of different ethnicities, and how each patient can be properly treated.

In his presentation at TMIOA, Dr. Inzucchi referenced several diabetes medications and glucose management methods that resulted in a reduction of stroke risk in patients.

The pulmonology and oncology expert panel returns for another discussion on lung cancer treatment challenges presented by the pandemic—and how the field can recover.

There are several clinical trials testing psychedelics as a treatment option for psychiatric disorders.

Now that the agent shows benefit in mitigating comorbid risks, the expert advocates for more timely diagnoses and treatment initiation.

A lack of PPE and high patient volumes were the leading causes of distress for nurses.

Depression is the leading cause of disability in the US.